Gray, E <br/><br/>
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.  [electronic resource] 

 -  Expert review of gastroenterology & hepatology  Jun 2017 
 - 593-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1747-4132 
<br/><br/><label>Standard No.: </label>10.1080/17474124.2017.1292850  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--adverse effects<br/>Genotype<br/>Health Services Accessibility<br/>Hepacivirus--drug effects<br/>Hepatitis C--complications<br/>Humans<br/>Ireland<br/>Liver Cirrhosis--diagnosis<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Program Evaluation<br/>Prospective Studies<br/>Registries<br/>Ribavirin--adverse effects<br/>Sofosbuvir<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Uridine Monophosphate--adverse effects